BeStock  
Markets › Compare › STOK vs NTLA

STOK vs NTLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
STOK · Stoke Therapeutics$25.32 ▼ 1.17%
NTLA · Intellia Therapeutics$12.75 ▲ 4.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

336290118146Oct 7, '25Apr 7, '26Oct 5, '26
  • STOK -7.3%
  • NTLA -37.6%

Head to head

MetricSTOKNTLA
Price$25.32$12.75
Change today▼ 1.17%▲ 4.00%
Market cap$1.63B$1.79B
Return, 3 months-23.3%-26.9%
Return, year to date-20.2%+41.8%
Return, 1 year-5.6%-37.9%
P/E (TTM)-7.6-3.8
P/B4.72.5
P/E percentile vs own 5y–64th
Dividend yield––
Revenue growth (YoY, latest qtr)-32.5%–
Net profit growth (YoY)-162.4%–
Gross margin––
Operating margin-809.7%–
Net margin-753.6%–
Return on equity-61.1%–
Analyst target vs. price+78.2%+60.8%
Analyst buy share100%50%
RSI (14)3457
30-day volatility45.2%46.6%
Max drawdown, 1 year-37.2%-71.3%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NTLA is the largest of the group by market value.
  • STOK has returned the most over the past year.
  • STOK carries the lowest trailing P/E.
  • STOK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top